BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23707346)

  • 1. Effect of 1,25(OH)2D3 on BALB/c mice infected with Leishmania mexicana.
    Ramos-Martínez E; Villaseñor-Cardoso MI; López-Vancell MR; García-Vázquez FJ; Pérez-Torres A; Salaiza-Suazo N; Pérez-Tamayo R
    Exp Parasitol; 2013 Aug; 134(4):413-21. PubMed ID: 23707346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The histopathological and immunological pattern of CBA mice infected with Leishmania amazonensis after treatment with pyrazole carbohydrazide derivatives.
    Charret KS; Lagrota-Cândido J; Carvalho-Pinto CE; Hottz CF; Lira ML; Rodrigues RF; Gomes AO; Bernardino AM; Canto-Cavalheiro MM; Leon LL; Amaral VF
    Exp Parasitol; 2013 Feb; 133(2):201-10. PubMed ID: 23219949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mast cells are activated by Leishmania mexicana LPG and regulate the disease outcome depending on the genetic background of the host.
    Villaseñor-Cardoso MI; Salaiza N; Delgado J; Gutiérrez-Kobeh L; Pérez-Torres A; Becker I
    Parasite Immunol; 2008 Aug; 30(8):425-34. PubMed ID: 18507782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice.
    Rosas LE; Keiser T; Barbi J; Satoskar AA; Septer A; Kaczmarek J; Lezama-Davila CM; Satoskar AR
    Int Immunol; 2005 Oct; 17(10):1347-57. PubMed ID: 16141242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of long-term treatment with pravastatin on the survival, evolution of cutaneous lesion and weight of animals infected by Leishmania amazonensis.
    Kückelhaus CS; Kückelhaus SA; Muniz-Junqueira MI
    Exp Parasitol; 2011 Mar; 127(3):658-64. PubMed ID: 21176775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of physalins purified from Physalis angulata in in vitro and in vivo models of cutaneous leishmaniasis.
    Guimarães ET; Lima MS; Santos LA; Ribeiro IM; Tomassini TB; Ribeiro dos Santos R; dos Santos WL; Soares MB
    J Antimicrob Chemother; 2009 Jul; 64(1):84-7. PubMed ID: 19454526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell responses to immunodominant LACK antigen do not play a critical role in determining susceptibility of BALB/c mice to Leishmania mexicana.
    Torrentera FA; Glaichenhaus N; Laman JD; Carlier Y
    Infect Immun; 2001 Jan; 69(1):617-21. PubMed ID: 11119565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leishmania mexicana H-line attenuated under pressure of gentamicin, potentiates a Th1 response and control of cutaneous leishmaniasis in BALB/c mice.
    Daneshvar H; Hagan P; Phillips RS
    Parasite Immunol; 2003; 25(11-12):589-96. PubMed ID: 15053780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D receptor signaling contributes to susceptibility to infection with Leishmania major.
    Ehrchen J; Helming L; Varga G; Pasche B; Loser K; Gunzer M; Sunderkötter C; Sorg C; Roth J; Lengeling A
    FASEB J; 2007 Oct; 21(12):3208-18. PubMed ID: 17551101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmania (Viannia) panamensis-induced cutaneous leishmaniasis in Balb/c mice: pathology.
    Rojas JI; Tani E; Orn A; Sánchez C; Goto H
    Int J Exp Pathol; 1993 Oct; 74(5):481-91. PubMed ID: 8217783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice.
    Rocha FJ; Schleicher U; Mattner J; Alber G; Bogdan C
    Infect Immun; 2007 Aug; 75(8):3823-32. PubMed ID: 17517868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal-lupane system as alternative chemotherapy against cutaneous leishmaniasis: macrophage as target cell.
    Barros NB; Migliaccio V; Facundo VA; Ciancaglini P; Stábeli RG; Nicolete R; Silva-Jardim I
    Exp Parasitol; 2013 Oct; 135(2):337-43. PubMed ID: 23933281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro control of Leishmania mexicana due to garlic-induced NO production.
    Gamboa-León MR; Aranda-González I; Mut-Martín M; García-Miss MR; Dumonteil E
    Scand J Immunol; 2007 Nov; 66(5):508-14. PubMed ID: 17953527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leishmania mexicana and Leishmania major: attenuation of wild-type parasites and vaccination with the attenuated lines.
    Daneshvar H; Coombs GH; Hagan P; Phillips RS
    J Infect Dis; 2003 May; 187(10):1662-8. PubMed ID: 12721947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in vivo activity of 1,3,4-thiadiazolium-2-aminide compounds in the treatment of cutaneous and visceral leishmaniasis.
    Rodrigues RF; Charret KS; Campos MC; Amaral V; Echevarria A; Dos Reis C; Canto-Cavalheiro MM; Leon LL
    J Antimicrob Chemother; 2012 Jan; 67(1):182-90. PubMed ID: 21987238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical treatment with nanoliposomal Amphotericin B reduces early lesion growth but fails to induce cure in an experimental model of cutaneous leishmaniasis caused by Leishmania mexicana.
    Varikuti S; Oghumu S; Saljoughian N; Pioso MS; Sedmak BE; Khamesipour A; Satoskar AR
    Acta Trop; 2017 Sep; 173():102-108. PubMed ID: 28602835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
    Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI
    Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of the specificity of seric IgA produced in response to antigens of Leishmania (Leishmania) mexicana in murine leishmaniasis].
    Pérez-Aguilar MC; Hernández O; Maizo de Segnini Z; Rojas CH; Díaz S; Alarcón M; Goncalves L
    Invest Clin; 2011 Sep; 52(3):216-29. PubMed ID: 21950193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo prophylactic and curative activity of the triterpene saponin PX-6518 against cutaneous Leishmania species.
    Inocêncio da Luz RA; Vermeersch M; Deschacht M; Hendrickx S; Van Assche T; Cos P; Maes L
    J Antimicrob Chemother; 2011 Feb; 66(2):350-3. PubMed ID: 21131319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,25(OH)2D3 inhibits in vitro and in vivo intracellular growth of apicomplexan parasite Toxoplasma gondii.
    Rajapakse R; Uring-Lambert B; Andarawewa KL; Rajapakse RP; Abou-Bacar A; Marcellin L; Candolfi E
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):811-4. PubMed ID: 17270431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.